11.04.2015 Views

surgical oncology sellsheet.pdf - Medel

surgical oncology sellsheet.pdf - Medel

surgical oncology sellsheet.pdf - Medel

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Transcollation ® Technology<br />

for Surgical Oncology<br />

Medtronic’s advanced energy devices use patented Transcollation technology – a combination of radiofrequency (RF)<br />

energy and saline – to provide hemostatic sealing of soft tissue and bone during surgery. When used during <strong>surgical</strong><br />

<strong>oncology</strong> procedures, monopolar sealers and Aquamantys® bipolar sealers provide benefits for surgeons and their<br />

patients by minimizing intra-operative blood loss, resulting in reduced transfusion rates. 1-3<br />

CLINICAL BENEFITS OF TRANSCOLLATION TECHNOLOGY<br />

• Reduces transfusion rates by minimizing intra-operative blood loss 1-3<br />

• Reduced transfusion rates contribute to reduced hospital length of stay 4,5<br />

• May reduce post-operative pancreatic leaks following distal pancreatectomy 6,7<br />

• Reduces the need for renal vascular clamping in partial nephrectomies 8<br />

SURGICAL APPLICATIONS<br />

• Liver resection<br />

• Pancreatectomy<br />

• Partial nephrectomy<br />

MONOPOLAR AND BIPOLAR SEALERS FOR SURGICAL ONCOLOGY<br />

Aquamantys 9.5 XL Bipolar Sealer<br />

Cone-shaped electrode design aids<br />

blunt dissection and hemostatic sealing<br />

Aquamantys 2.3 Bipolar Sealer<br />

Medium-sized electrodes provide<br />

hemostatic sealing of bleeding soft<br />

tissue and bone<br />

Aquamantys 6.0 Bipolar Sealer<br />

Large-sized electrodes provide<br />

hemostatic sealing of bleeding<br />

soft tissue and bone<br />

EndoSH-2.0<br />

Monopolar sealer featuring a<br />

unique hook electrode designed<br />

to aid in blunt dissection and<br />

hemostatic sealing of soft tissue<br />

in laparoscopic procedures


TRANSCOLLATION ® TECHNOLOGY FOR SURGICAL ONCOLOGY<br />

Transcollation® Technology<br />

Transcollation technology combines radiofrequency (RF)<br />

energy and saline for hemostatic sealing of soft tissue<br />

and bone at the <strong>surgical</strong> site. Vessels up to 1 mm may<br />

be occluded, reducing bleeding.<br />

Aquamantys® System<br />

The Aquamantys System delivers Transcollation<br />

technology through a proprietary RF generator and a<br />

single-use disposable bipolar sealer.<br />

References<br />

Ordering Information<br />

Description<br />

Catalog Number<br />

Aquamantys 9.5 XL Bipolar Sealer ....................................................... 23-313-1<br />

Aquamantys 6.0 Bipolar Sealer ............................................................. 23-112-1<br />

Aquamantys 2.3 Bipolar Sealer ............................................................. 23-113-1<br />

Aquamantys Pump Generator .............................................................. 40-402-1<br />

EndoSH2.0 Monopolar Sealer ............................................................ 13-201-1<br />

EndoFB3.0 Monopolar Sealer ............................................................. 12-201-1<br />

DS3.0 Dissecting Sealer ........................................................................ 13-101-1<br />

DS3.5C Dissecting Sealer ..................................................................... 13-121-1<br />

1. Geller DA, Tsung A, Maheshwari V, Rutstein LA, Fung JJ, Marsh JW. Hepatic resection in 170 patients using saline-cooled radiofrequency coagulation. HPB 2005; 7:<br />

208–213.<br />

2. Marulanda GA, Ulrich SD, et al. Reductions in blood loss with a bipolar sealer in total hip arthroplasty. Expert Rev Med Devices 2008; 5:125-131.<br />

3. Performance has not been specifically established in all procedures.<br />

4. Covance report; 2008 MedPAR database based on ICD-9-CM Codes for 100% of Medicare beneficiaries.<br />

5. Covance MedPAR report. Length of stay has not been specifically correlated with Transcollation technology.<br />

6. Performance has been demonstrated in a pre-clinical model.<br />

7. Truty MJ, Sawyer MD, Que FG. Decreasing pancreatic leak after distal pancreatectomy: saline-coupled radiofrequency ablation in a porcine model. J Gastrointest Surg<br />

2007; 1:998-1007.<br />

8. Urena R, Mendez F, Woods M, Thomas R, Davis R. Laparoscopic partial nephrectomy of solid renal masses without Hilar clamping using a monopolar radiofrequency<br />

device. Journal of Urology, 2004 Mar; 171(3):1054-6.<br />

Caution: Federal Law (USA) restricts these devices to sale by or on the order of a physician. For a listing of indications, contraindications, precautions, and warnings, please refer to the<br />

Instructions For Use (IFU) that accompany Aquamantys disposable devices and/or the Aquamantys System User Guide.<br />

For further information, please call 866-777-9400.<br />

You may also consult our website:<br />

www.medtronic.com/advancedenergy<br />

Medtronic Advanced Energy, LLC<br />

Medtronic USA, Inc.<br />

180 International Drive<br />

Portsmouth, NH 03801<br />

USA<br />

www.medtronic.com/advancedenergy<br />

Tel: (866) 777-9400<br />

Fax: (866) 222-0900<br />

© 2011, Medtronic, Inc. All rights reserved. Aquamantys®, the Aquamantys® logo and Transcollation® are registered<br />

trademarks of Medtronic, Inc.<br />

71-10-2255 10.11 Rev D

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!